Displaying drugs 76 - 100 of 654 in total
Influenza A virus A/South Australia/55/2014 IVR-175 (H3N2) hemagglutinin antigen (propiolactone inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/South Australia/55/2014 IVR-175 (H3N2) hemagglutinin antigen (propiolactone inactivated …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (UV, formaldehyde inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (UV, formaldehyde inactivated …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) hemagglutinin antigen (UV, formaldehyde inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) hemagglutinin antigen (UV, formaldehyde inactivated …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/Hong Kong/4801/2014 X-263B (H3N2) hemagglutinin antigen (propiolactone inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Hong Kong/4801/2014 X-263B (H3N2) hemagglutinin antigen (propiolactone inactivated …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) hemagglutinin antigen (UV, formaldehyde inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) hemagglutinin antigen (UV, formaldehyde inactivated …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/Guangdong-Maonan/SWL1536/2019 CNIC-1909 (H1N1) antigen (UV, formaldehyde inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Guangdong-Maonan/SWL1536/2019 CNIC-1909 (H1N1) antigen (UV, formaldehyde inactivated …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/Hong Kong/2671/2019 NIB-121 (H3N2) antigen (UV, formaldehyde inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Hong Kong/2671/2019 NIB-121 (H3N2) antigen (UV, formaldehyde inactivated) …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (UV, formaldehyde inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Singapore/INFIMH-16-0019/2016 IVR-186 (H3N2) antigen (UV, formaldehyde inactivated …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/North carolina/04/2016 (H3N2) hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/North carolina/04/2016 (H3N2) hemagglutinin antigen (MDCK cell derived, propiolactone …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza B virus B/Singapore/INFTT-16-0610/2016 hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza B virus B/Singapore/INFTT-16-0610/2016 hemagglutinin antigen (MDCK cell derived, propiolactone …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) hemagglutinin antigen (MDCK cell derived, propiolactone inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence...
Approved
Matched Name: … Influenza A virus A/Singapore/gp1908/2015 IVR-180 (H1N1) hemagglutinin antigen (MDCK cell derived, propiolactone …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Matched Description: … virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". ... the virus as there are circulating antibodies that recognize that particular component of the virus ... Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the …
Ebola Zaire vaccine (live, attenuated)
Ebola virus vaccine is a vaccine used to prevent Ebola virus disease caused by Zaire ebolavirus in adults, prevent outbreaks, and reduce the extent of the virus spreading in case of outbreaks. Ebola virus disease, formerly known as Ebola hemorrhagic fever, is a rare but severe and often deadly disease....
Approved
Matched Synonyms: … (G) replaced with the Zaire Ebola Virus (ZEBOV) Kikwit 1995 strain surface glycoprotein (GP) ... Recombinant Vesicular Stomatitis Virus (rVSV) strain Indiana with a deletion of the VSV envelope glycoprotein …
Matched Description: … Ebola virus vaccine is a vaccine used to prevent Ebola virus disease caused by _Zaire ebolavirus_ in ... adults, prevent outbreaks, and reduce the extent of the virus spreading in case of outbreaks. ... [L10854] Ebola virus disease, formerly known as Ebola hemorrhagic fever, is a rare but severe and often …
Matched Description: … Ebola virus vaccine is a vaccine used to prevent Ebola virus disease caused by _Zaire ebolavirus_ in ... adults, prevent outbreaks, and reduce the extent of the virus spreading in case of outbreaks. ... [L10854] Ebola virus disease, formerly known as Ebola hemorrhagic fever, is a rare but severe and often …
Valoctocogene roxaparvovec
Valoctocogene roxaparvovec is an adeno-associated virus serotype 5 (AAV5) based gene therapy vector that expresses the B-domain deleted SQ form of human coagulation factor VIII (hFVIII-SQ). The expression of hFVIII-SQ is driven by a liver-specific promoter, which enables hepatocytes to produce factor VIII protein and increase the levels of active...
Approved
Investigational
Matched Synonyms: … DNA (synthetic adeno-associated virus 5 vector BMN 270 human blood-coagulation factor VIII SQ variant-specifying …
Matched Description: … Valoctocogene roxaparvovec is an adeno-associated virus serotype 5 (AAV5) based gene therapy vector that …
Matched Description: … Valoctocogene roxaparvovec is an adeno-associated virus serotype 5 (AAV5) based gene therapy vector that …
Beremagene geperpavec
Beremagene geperpavec is a live, replication-defective herpes simplex virus type 1 (HSV-1)-based vector therapy. Developed by Krystal Biotech, it was first approved by the FDA on May 19, 2023, for the treatment of wounds associated with dystrophic epidermolysis bullosa (DEB). DEB is caused by mutations in the COL7A1 gene that...
Approved
Matched Synonyms: … Dna (recombinant herpes simplex virus type 1 strain kos plasmid vector kb103 human collagen col7a1-specifying …
Matched Description: … Beremagene geperpavec is a live, replication-defective herpes simplex virus type 1 (HSV-1)-based vector …
Matched Description: … Beremagene geperpavec is a live, replication-defective herpes simplex virus type 1 (HSV-1)-based vector …
Nirsevimab
Nirsevimab (MEDI8897) is a recombinant human immunoglobulin G1 kappa (IgG1ĸ) monoclonal antibody used to prevent respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and infants. It binds to the prefusion conformation of the RSV F protein, a glycoprotein involved in the membrane fusion step of the viral entry...
Approved
Investigational
Matched Synonyms: … Immunoglobulin g1-kappa, anti-(human respiratory syncytial virus fusion glycoprotein f0 (protein f))human ... Immunoglobulin g1, anti-(human respiratory syncytial virus fusion protein)(human monoclonal med18897 …
Matched Description: … recombinant human immunoglobulin G1 kappa (IgG1ĸ) monoclonal antibody used to prevent respiratory syncytial virus …
Matched Categories: … Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody …
Matched Description: … recombinant human immunoglobulin G1 kappa (IgG1ĸ) monoclonal antibody used to prevent respiratory syncytial virus …
Matched Categories: … Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody …
Hepatitis B Vaccine (Recombinant)
Hepatitis B Vaccine is an ingredient in the EMA-withdrawn product Quintanrix. It is marketed in Canada as Engerix B. It is also a part of Twinrix (Hep A/Hep B vaccine) available also in Canada.
The hepatitis B virus induces a severe form of viral hepatitis. Other causative agents are hepatitis...
Approved
Withdrawn
Matched Synonyms: … Hepatitis B virus hbsag surface protein antigen …
Matched Description: … Hepatitis D virus, a defective virus requiring the “keeper function” of the hepatitis B virus, occurs ... The hepatitis B virus induces a severe form of viral hepatitis. ... Other causative agents are hepatitis A virus, and the non-A, non-B hepatitis viruses. …
Matched Salts name: … Hepatitis B virus subtype ADW HBSAG surface protein antigen ... Hepatitis B virus subtype ADW2 HBSAG surface protein antigen …
Matched Categories: … Inactivated Hepatitis B Virus Vaccine …
Matched Description: … Hepatitis D virus, a defective virus requiring the “keeper function” of the hepatitis B virus, occurs ... The hepatitis B virus induces a severe form of viral hepatitis. ... Other causative agents are hepatitis A virus, and the non-A, non-B hepatitis viruses. …
Matched Salts name: … Hepatitis B virus subtype ADW HBSAG surface protein antigen ... Hepatitis B virus subtype ADW2 HBSAG surface protein antigen …
Matched Categories: … Inactivated Hepatitis B Virus Vaccine …
Magnesium trisilicate
Magnesium trisilicate is an inorganic compound that is used as an antacid in the treatment of peptic ulcers.
Approved
Matched Products: … Virus Blocker Cl-40 …
Curcumin
Curcumin, also known as diferuloylmethane, is an active component in the golden spice turmeric (Curcuma longa) and in Curcuma xanthorrhiza oil. It is a highly pleiotropic molecule that exhibits antibacterial, anti-inflammatory, hypoglycemic, antioxidant, wound-healing, and antimicrobial activities . Due to these properties, curcumin has been investigated for the treatment and...
Approved
Investigational
Matched Products: … Victory 19 Virus Out …
Human papillomavirus type 58 L1 capsid protein antigen
Human papillomavirus type 58 L1 capsid protein antigen is contained in Gardasil is a vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) type 58. The vaccine is prepared from the purified...
Approved
Matched Description: … The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein …
Matched Mixtures name: … GARDASIL® 9 VACUNA RECOMBINANTE NONAVALENTE CONTRA EL VIRUS DEL PAPILOMA HUMANO …
Matched Mixtures name: … GARDASIL® 9 VACUNA RECOMBINANTE NONAVALENTE CONTRA EL VIRUS DEL PAPILOMA HUMANO …
Human papillomavirus type 11 L1 capsid protein antigen
Human papillomavirus type 11 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus...
Approved
Matched Description: … The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein …
Matched Mixtures name: … GARDASIL® 9 VACUNA RECOMBINANTE NONAVALENTE CONTRA EL VIRUS DEL PAPILOMA HUMANO …
Matched Mixtures name: … GARDASIL® 9 VACUNA RECOMBINANTE NONAVALENTE CONTRA EL VIRUS DEL PAPILOMA HUMANO …
Recombinant stabilized RSV B prefusion F antigen
Recombinant stabilized RSV B prefusion F antigen is one component of a bivalent respiratory syncytial virus (RSV) vaccine called Abrysvo. The vaccine comprises two antigens - the other being recombinant stabilized RSV A prefusion F antigen - which have been expressed in Chinese hamster ovary cell lines and then purified...
Approved
Matched Description: … Recombinant stabilized RSV B prefusion F antigen is one component of a bivalent respiratory syncytial virus ... [L48066] In contrast to another RSV vaccine, [respiratory syncytial virus vaccine, adjuvanted] (Arexvy …
Matched Categories: … Respiratory syncytial virus (RSV) vaccines …
Matched Categories: … Respiratory syncytial virus (RSV) vaccines …
Tecovirimat
The World Health Organization declared smallpox, a contagious and sometimes fatal infectious disease, eradicated in 1980. However, there have been longstanding concerns that smallpox may be used as a bioweapon.[A35133,L3614] Tecovirimat is an antiviral drug that was identified via a high-throughput screen in 2002. It is effective against all orthopoxviruses,...
Approved
Investigational
Matched Description: … orthopoxviruses, including vaccinia, cowpox, ectromelia, rabbitpox, monkeypox, and Variola (smallpox) virus ... than smallpox, tecovirimat is also indicated to treat complications due to replication of the vaccinia virus …
Miglustat
Miglustat, commonly marketed under the trade name Zavesca, is a drug used to treat Gaucher disease. It inhibits the enzyme glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids. It is only used for patients who cannot be treated with enzyme replacement therapy with imiglucerase. Miglustat is now...
Approved
Famciclovir
Famciclovir, marketed as Famvir by Novartis, is a guanine analogue used to treat herpes virus infections. It is most commonly used to treat herpes zoster (shingles). Famciclovir is a prodrug of penciclovir with higher oral bioavailability.
Approved
Investigational
Matched Description: … Famciclovir, marketed as Famvir by Novartis, is a guanine analogue used to treat herpes virus infections …
Matched Categories: … Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor …
Matched Categories: … Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor …
Human varicella-zoster immune globulin
Human varicella-zoster immune globulin is a solvent/detergent-treated sterile liquid preparation of purified human immune globulin G (IgG) containing antibodies to varicella zoster virus (anti-VZV). It is prepared from pools of healthy human donors' plasma via anion-exchange column chromatography and was approved in 2012 under the name VariZIG to reduce the...
Approved
Matched Description: … liquid preparation of purified human immune globulin G (IgG) containing antibodies to varicella zoster virus ... The therapeutic efficacy is proven if administered within 4 days of exposure to varicella zoster virus …
Displaying drugs 76 - 100 of 654 in total